AnalystsDebanjana Chatterjee
Debanjana Chatterjee's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 24%
#1243 out of 5296 analysts
Average Return
+27.02%
Win Rate
78%14 out of 18
Risk vs Reward
Poor
Good

Debanjana Chatterjee's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Spyre Therapeutics IncSYRE
+181.89%$28.66$80.79
2025-12-01 -
2026-06-12
Strong Buy
Contineum Therapeutics IncCTNM
+94.12%$7.14$13.86
2025-03-13 -
2026-03-12
Strong Buy
Sionna Therapeutics IncSION
+66.14%$21.62$35.92
2025-09-08 -
2026-06-12
Strong Buy
Theravance Biopharma IncTBPH
+56.98%$10.60$16.64
2025-06-17 -
2026-06-12
Strong Buy
Abcellera Biologics IncABCL
+48.02%$3.54$5.24
2026-04-10 -
2026-06-12
Strong Buy

Debanjana Chatterjee Analyst Color

Get additional color on Debanjana Chatterjee's coverage of popular stocks

Debanjana Chatterjee's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Sionna Therapeutics IncSION
2Strong Buy$63.00+75.39%Maintains
2 months ago
Spyre Therapeutics IncSYRE
2Strong Buy$95.00+17.59%Maintains
2 months ago
Mindwalk Holdings CorpHYFT
1Strong Buy$5.00+220.51%Initiates Coverage On
2 months ago
Abcellera Biologics IncABCL
1Strong Buy$11.00+109.92%Initiates Coverage On
2 months ago
Trevi Therapeutics IncTRVI
1Strong Buy$24.00+68.90%Maintains
3 months ago
Intellia Therapeutics IncNTLA
2Strong Buy$29.00+139.47%Upgrades
3 months ago
Armata Pharmaceuticals IncARMP
1Strong Buy$15.00+97.89%Initiates Coverage On
5 months ago
Theravance Biopharma IncTBPH
1Strong Buy$24.00+44.23%Initiates Coverage On
a year ago
Sagimet Biosciences IncSGMT
2Strong Buy$27.00N/AMaintains
a year ago
Tvardi Therapeutics IncTVRD
1Strong Buy$39.00N/AInitiates Coverage On
a year ago
Kalvista Pharmaceuticals IncKALV
2Strong Buy$30.00N/AMaintains
a year ago
Contineum Therapeutics IncCTNM
1Strong Buy$23.00N/AInitiates Coverage On
a year ago
Pharvaris NvPHVS
1Strong Buy$46.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.